B7VPF3 AF NFT

Thiopurine S-methyltransferase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiaf4ts4uv56g2o4humkf3qxwbtxaflw7ps4olcsm4rovslvb3jdpy/metadata.json
IPFS of structure file: 
bafybeica2hjxb3olvxhawk6ywrftmhpzf45clumheifidtj6obymt7c3o4/AF-B7VPF3-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x00015c671bd119DC86Baf28AF2eB830022fb46C1
First NFT owner address (bech32): 
genesis1qqq4cecm6yvaep46729096urqq30k3kp0yml0z
Current NFT ID #471484 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
471484
Accession (UniProt):
B7VPF3
Name::
Thiopurine S-methyltransferase
Experimental Method:
Predicted structure
Sequence source:
Vibrio atlanticus (strain LGP32)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B7VPF3 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B7VPF3|TPMT_VIBA3 Thiopurine S-methyltransferase OS=Vibrio atlanticus (strain LGP32) OX=575788 GN=tpm PE=3 SV=1 MNNPEFWHNKWAANQIGFHLEDVNPLLIKFWEKTEPNYEKSVFVPLCGKSEDLIWLATKHEEVQGVELSQIAVRAFFAEHLYTPTVTQISGQHELYQFDELNIYTGDYFTAPIQPVDTIYDRASLVALPAEIRAQYVERLKQLLKPGGKILLVTLDYDQSEMAGPPFSVPKLEIDQLFAGYKITLLNQDIADDEHPKIAKKGLSRFSEEVYLIESEA